Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	12/15/2004 5:21:22 AM
	Read Replies (1) of 946

Cell Therapeutics CEO sells chunk of stock Cell Therapeutics reported yesterday that Chief Executive James Bianco has sold about 13,000 shares of the company's stock at $7.50 to $7.65 a share, generating about $100,000. The proceeds from the sale were used mainly to cover taxes related to the vesting of restricted stock awards, according to a filing with the Securities and Exchange Commission (SEC). The sale represents about 2 percent of Bianco's shares in the Seattle biotech company. He still has 574,597 shares, according to the filing. Other Cell Therapeutics executives, including Chief Financial Officer Louis Bianco and Chief Medical Officer Jack Singer, reported stock sales for similar reasons. seattletimes.nwsource.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next